Locations
Vancouver, WA, USA · North America · Seattle, WA, USA
industry
Biotechnology · Data and Analytics · DeepTech · Health · Software
Size
51-200 employees
Stage
Other
founded in
2011
AbSci is a synthetic biology company that translates ideas into drugs with a platform technology that reinvents the biopharmaceutical drug discovery process. They custom engineer E. coli to create novel complex biologics in their full length format while simultaneously developing production cell lines. The company is deploying cutting-edge deep learning artificial intelligence to inform their designs, and every day we succeed in achieving things others have dismissed as impossible.
Something looks off?On-site & Remote